{
    "nctId": "NCT06130241",
    "briefTitle": "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?",
    "officialTitle": "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Sentinel Lymph Node",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection?",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patients with operable breast cancer who had node-positive disease at presentation and pathological confirmation with either FNA or core biopsy\n2. Female Patient aged from 18 to 60 years old\n3. Patients who are fit for general anesthesia.\n4. Patient who agree to provide short term outcome data and agree to provide contact information to provide contact information.\n\nExclusion Criteria:\n\n1. Stage 4 breast cancer\n2. Patient has no clinical response to NACT\n3. Patients who are contraindicated for radiotherapy\n4. Pregnant patients in first trimester\n5. Patient with inflammatory carcinoma",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}